Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of DF3/MUC1 regulated expression in gene therapy

Use of DF3/MUC1 regulated expression in gene therapy

US Patent 7247297 · Granted Jul 24, 2007

Estimated economic value: $32,547,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies against the MUC1-c/extracellular domain (MUC1-C/ECD)2025
System and method for multi-site radiotherapy2024
Polymeric nanoparticles providing nucleic acids encoding TNF-α2022
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)2021
Compositions and methods of treating cancer2021
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)2020
Anti-tumor therapy2020
Anti-tumor therapy2019
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)2018
Combination anti-human epidermal growth factor receptor 2 (anti-HER2) cancer the2017
Anti-tumor therapy2017
Compositions and methods for treating cancer2017